The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
fair enough. surprised Reuters reported it, probably just because it is Oxford.
again, what's your point?
what's your point?
discussed already, see posts when RNS was released.
no emotions, nothing against other companies, its just confidence in the potential of affimers and Avacta. DYOR.
even just a quick look at the Leeds uni website provides a good overview of what affimers can do:
https://biologicalsciences.leeds.ac.uk/facilities/doc/affimer-screening-facility
this post by Infinitynbeyond got 58 recommendations yesterday:
Mortgage, I'm an occasional poster on here and like many I work so only get the odd occasion to check the board. Unfortunately, your posts, and the inevitable replies clog the board with nonsense and prevent us being able to pick up the salient and informative posts.
Those of us that read regularly are fully aware of your position and perspective and we'd therefore be grateful if you'd either give us a different perspective or stop repeating yourself over and over, it really is becoming tiresome.
Skin-go back to the betfred store
I know from colleagues talking to people in all major Pharma companies, that the press is by far too optimistic about the availability of a vaccine. But good to know that your major source of information is the DM.
this briefing written by a freelance journalist is of disappointing quality for bmj. it ignores the current consent that the best approach to contain the virus is frequent testing. A much better article to read is
https://www.nejm.org/doi/full/10.1056/NEJMp2025631
but AS already told us that.
if not today, it will happen tomorrow. This upward movement is not driven by sentiment, it is sheer confidence in affirmers and avacta.
Last paragraph from the article:
"To defeat Covid-19, we believe that the FDA, the CDC, the National Institutes of Health, and others must encourage structured evaluations of tests in the context of planned testing regimens to identify those that will provide the best Covid filters. Frequent use of cheap, simple, rapid tests will accomplish that aim, even if their analytic sensitivities are vastly inferior to those of benchmark tests.1 Such a regimen can help us stop Covid in its tracks."
All governments in the world know this by now. Avacta will go global!
probably lost some money already following his genius strategy
Hardcore- Wow, well observed - so?. It will be up, and down, and up, and down, and up, and down, and up, and down, ... If you predict the sequence right, you can become a millionaire indeed. Just try, but don't forget that this is the main reason why investors lose money.
Hardcore. Thank you for the advise, but it's useless. Believe me, I spent too much time trying to bead the market, and I can tell you it won't work. I do not get the impression you are smart enough to proof me wrong, and I strongly recommend you to stick to the old fashioned way.
if you cannot add up one and one, go ahead. Avacta's trajectory has never been clearer. "Vorsprung durch biotechnology"
it is amazing that you can just order it online like that. Hopefully it will fly.
Indeed, and I am so fed up with the day traders. You cannot win!